Dopamine D1 receptor-mediated intracellular responses in the hypothalamus after co-administration of caffeine with MDMA.

作者: Natacha Vanattou-Saïfoudine , Brendan Behan , Andrew Harkin

DOI: 10.1111/J.1742-7843.2011.00805.X

关键词: MDMAReceptor antagonistCREBChemistryDopamineImmediate early geneSCH-23390PharmacologyDopamine receptor D1Caffeine

摘要: Markers of dopamine D(1) receptor activation were determined to elucidate intracellular mechanisms associated with the combined effects caffeine and 3,4 methylenedioxymethamphetamine (MDMA), reported previously produce increased toxicity, when compared either drug alone. Caffeine (10 mg/kg) MDMA (15 mg/kg) administered male Sprague Dawley rats alone in combination. One hour after administration, core body temperature phosphorylation -related markers, cAMP response element binding protein (CREB), c-AMP-regulated phosphoprotein 32 kDa (DARPP-32) expression immediate early gene cellular marker c-fos hypothalamus. Co-administration or treatment Pre-treatment antagonist SCH 23390 (1 mg/kg, i.p.), 30 min. prior produced a hypothermic that was unaffected by caffeine. p-CREB, p-DARPP-32 SCH-23390 attenuated changes p-DARPP c-fos. The results show an enhanced is but not agent suggestive synergistic actions convergent on signalling pathway. A dopamine-related synergy administration may have important use safety implications for recreational users.

参考文章(45)
A M Graybiel, J J Canales, Patterns of gene expression and behavior induced by chronic dopamine treatments. Annals of Neurology. ,vol. 47, ,(2000)
T. Hökfelt, G. Foster, M. Schultzberg, B. Meister, M. Schalling, M. Goldstein, H. C. Hemmings, C. Ouimet, P. Greengard, DARPP-32 as a marker for D-1 dopaminoceptive cells in the rat brain: prenatal development and presence in glial elements (tanycytes) in the basal hypothalamus. Advances in Experimental Medicine and Biology. ,vol. 235, pp. 65- 82 ,(1988) , 10.1007/978-1-4899-2723-1_6
N Vanattou-Saïfoudine, R McNamara, A Harkin, Mechanisms mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in rats. British Journal of Pharmacology. ,vol. 160, pp. 860- 877 ,(2010) , 10.1111/J.1476-5381.2010.00660.X
SJ Boyson, P McGonigle, PB Molinoff, Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain The Journal of Neuroscience. ,vol. 6, pp. 3177- 3188 ,(1986) , 10.1523/JNEUROSCI.06-11-03177.1986
A Richard Green, Esther O'Shea, Kathryn S Saadat, J Martin Elliott, M Isabel Colado, Studies on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures. British Journal of Pharmacology. ,vol. 146, pp. 306- 312 ,(2005) , 10.1038/SJ.BJP.0706318
C.P. Stephenson, G.E. Hunt, A.N. Topple, I.S. McGregor, The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"-induced c-fos expression in rat brain. Neuroscience. ,vol. 92, pp. 1011- 1023 ,(1999) , 10.1016/S0306-4522(99)00049-4
Maïté Hotte, Sébastien Thuault, Fabienne Lachaise, Kelly T. Dineley, Hugh C. Hemmings, Angus C. Nairn, Thérèse M. Jay, D1 receptor modulation of memory retrieval performance is associated with changes in pCREB and pDARPP-32 in rat prefrontal cortex Behavioural Brain Research. ,vol. 171, pp. 127- 133 ,(2006) , 10.1016/J.BBR.2006.03.026
J.-S. Lin, Y. Hou, M. Jouvet, Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat Proceedings of the National Academy of Sciences of the United States of America. ,vol. 93, pp. 14128- 14133 ,(1996) , 10.1073/PNAS.93.24.14128
Natacha Vanattou-Saïfoudine, Ruth McNamara, Andrew Harkin, Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA ('ecstasy'). Psychopharmacology. ,vol. 211, pp. 15- 25 ,(2010) , 10.1007/S00213-010-1864-1